Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Examining the cost-effectiveness of baseline left ventricular function assessment among breast cancer patients undergoing anthracycline-based therapy.

Abu-Khalaf MM, Safonov A, Stratton J, Wang S, Hatzis C, Park E, Pusztai L, Gross CP, Russell R.

Breast Cancer Res Treat. 2019 Jul;176(2):261-270. doi: 10.1007/s10549-019-05178-z. Epub 2019 Apr 24. Review.

PMID:
31020471
2.

Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA.

Ye Z, Wang C, Wan S, Mu Z, Zhang Z, Abu-Khalaf MM, Fellin FM, Silver DP, Neupane M, Jaslow RJ, Bhattacharya S, Tsangaris TN, Chervoneva I, Berger A, Austin L, Palazzo JP, Myers RE, Pancholy N, Toorkey D, Yao K, Krall M, Li X, Chen X, Fu X, Xing J, Hou L, Wei Q, Li B, Cristofanilli M, Yang H.

Eur J Cancer. 2019 Jan;106:133-143. doi: 10.1016/j.ejca.2018.10.012. Epub 2018 Dec 4.

PMID:
30528798
3.

Racial and Ethnic Disparities in Oncotype DX Test Receipt in a Statewide Population-Based Study.

Davis BA, Aminawung JA, Abu-Khalaf MM, Evans SB, Su K, Mehta R, Wang SY, Gross CP.

J Natl Compr Canc Netw. 2017 Mar;15(3):346-354.

PMID:
28275035
4.

Chemotherapy for Elderly Ovarian Cancer Patients.

Muralikrishnan S, Hatzis C, Katz A, Santin A, Schwartz PE, Abu-Khalaf MM.

Gynecol Obstet (Sunnyvale). 2016 Aug;6(8). pii: 397. Epub 2016 Aug 31.

5.

Efficacy and tolerability of combination cisplatin and ifosfamide chemotherapy with vaginal cuff brachytherapy in the first line treatment of uterine carcinosarcoma.

Abu-Khalaf MM, Raza MA, Hatzis C, Wang H, Lin K, Higgins S, Ratner E, Silasi DA, Azodi M, Rutherford TJ, Santin AD, Schwartz PE.

Eur J Gynaecol Oncol. 2016;37(2):199-203.

PMID:
27172745
6.

Patient preferences regarding incidental genomic findings discovered during tumor profiling.

Yushak ML, Han G, Bouberhan S, Epstein L, DiGiovanna MP, Mougalian SS, Sanft TB, Abu-Khalaf MM, Chung GG, Stein SM, Goldberg SB, Pusztai L, Hofstatter EW.

Cancer. 2016 May 15;122(10):1588-97. doi: 10.1002/cncr.29951. Epub 2016 Mar 11.

7.

New Strategies in Breast Cancer: Immunotherapy.

Pusztai L, Karn T, Safonov A, Abu-Khalaf MM, Bianchini G.

Clin Cancer Res. 2016 May 1;22(9):2105-10. doi: 10.1158/1078-0432.CCR-15-1315. Epub 2016 Feb 11.

8.

Immune Signatures Following Single Dose Trastuzumab Predict Pathologic Response to PreoperativeTrastuzumab and Chemotherapy in HER2-Positive Early Breast Cancer.

Varadan V, Gilmore H, Miskimen KL, Tuck D, Parsai S, Awadallah A, Krop IE, Winer EP, Bossuyt V, Somlo G, Abu-Khalaf MM, Fenton MA, Sikov W, Harris LN.

Clin Cancer Res. 2016 Jul 1;22(13):3249-59. doi: 10.1158/1078-0432.CCR-15-2021. Epub 2016 Feb 3.

9.

Association of 21-gene recurrence score assay and adjuvant chemotherapy use in the medicare population, 2008-2011.

Su KW, Hall J, Soulos PR, Abu-Khalaf MM, Evans SB, Mougalian SS, Rutter CE, Davidoff AJ, Gross CP.

J Geriatr Oncol. 2016 Jan;7(1):15-23. doi: 10.1016/j.jgo.2015.11.002. Epub 2015 Dec 17.

PMID:
26704661
10.

Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States.

Mougalian SS, Soulos PR, Killelea BK, Lannin DR, Abu-Khalaf MM, DiGiovanna MP, Sanft TB, Pusztai L, Gross CP, Chagpar AB.

Cancer. 2015 Aug 1;121(15):2544-52. doi: 10.1002/cncr.29348. Epub 2015 Apr 22.

11.

Intrasplenic Arterial Aneurysms during Pregnancy.

Abu-Khalaf MM, Al-Ameer SM, Smadi MM, Qatawneh A, Smara OA, Hadidy AT.

Case Rep Obstet Gynecol. 2015;2015:248141. doi: 10.1155/2015/248141. Epub 2015 Feb 24.

12.

Systematic approach to providing breast cancer survivors with survivorship care plans: a feasibility study.

Bulloch KJ, Irwin ML, Chagpar AB, Pusztai L, Killelea BK, Horowitz NR, Hofstatter EW, Abu-Khalaf MM, DiGiovanna M, Chung GG, Sanft TB.

J Oncol Pract. 2015 Mar;11(2):e170-6. doi: 10.1200/JOP.2015.005173. Erratum in: J Oncol Pract. 2015 May;11(3):265.

PMID:
25784577
13.

Sirolimus and trastuzumab combination therapy for HER2-positive metastatic breast cancer after progression on prior trastuzumab therapy.

Acevedo-Gadea C, Hatzis C, Chung G, Fishbach N, Lezon-Geyda K, Zelterman D, DiGiovanna MP, Harris L, Abu-Khalaf MM.

Breast Cancer Res Treat. 2015 Feb;150(1):157-67. doi: 10.1007/s10549-015-3292-8. Epub 2015 Feb 17.

PMID:
25687356
14.

Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin-bound paclitaxel in patients with advanced solid tumors.

Abu-Khalaf MM, Baumgart MA, Gettinger SN, Doddamane I, Tuck DP, Hou S, Chen N, Sullivan C, Lezon-Geyda K, Zelterman D, Hatzis C, Deshpande H, Digiovanna MP, Azodi M, Schwartz PE, Harris LN.

Cancer. 2015 Jun 1;121(11):1817-26. doi: 10.1002/cncr.29254. Epub 2015 Feb 3.

15.

Quantitative measurements of HER2 and phospho-HER2 expression: correlation with pathologic response to neoadjuvant chemotherapy and trastuzumab.

Cheng H, Bai Y, Sikov W, Sinclair N, Bossuyt V, Abu-Khalaf MM, Harris LN, Rimm DL.

BMC Cancer. 2014 May 8;14:326. doi: 10.1186/1471-2407-14-326.

16.

Phase I clinical trial of the mammalian target of rapamycin inhibitor everolimus in combination with oral topotecan for recurrent and advanced endometrial cancer.

Acevedo-Gadea C, Santin AD, Higgins SA, Urva S, Ratner E, Silasi DA, Azodi M, Rutherford T, Schwartz PE, Abu-Khalaf MM.

Int J Gynecol Cancer. 2014 Mar;24(3):528-33. doi: 10.1097/IGC.0000000000000085.

PMID:
24557436
17.

The cost of breast cancer screening in the Medicare population.

Gross CP, Long JB, Ross JS, Abu-Khalaf MM, Wang R, Killelea BK, Gold HT, Chagpar AB, Ma X.

JAMA Intern Med. 2013 Feb 11;173(3):220-6. doi: 10.1001/jamainternmed.2013.1397.

18.

Cancer therapy related cardiotoxicity.

Abu-Khalaf MM, Bader F.

Curr Cardiol Rev. 2011 Nov;7(4):213. No abstract available.

19.

DTCs/CTCs in breast cancer: five decades later.

Alsamarai S, Abu-Khalaf MM, Harris LN.

Recent Results Cancer Res. 2012;195:217-25. doi: 10.1007/978-3-642-28160-0_20. Review.

PMID:
22527509
20.

Uncommon incidental pseudoaneurysm. Diagnostic and management challenges.

Hadidy AM, Samara OA, Takrouri HS, Al-Ryalat NT, Al-Smady MM, Ryalat ST, Abu-Khalaf MM.

Saudi Med J. 2009 Aug;30(8):1037-43.

PMID:
19668884
21.

Ocular complications of cancer therapy: a primer for the ophthalmologist treating cancer patients.

Hazin R, Abuzetun JY, Daoud YJ, Abu-Khalaf MM.

Curr Opin Ophthalmol. 2009 Jul;20(4):308-17. doi: 10.1097/ICU.0b013e32832c9007. Review.

PMID:
19491683
22.

Anthracycline-induced cardiotoxicity: risk assessment and management.

Abu-Khalaf MM, Harris L.

Oncology (Williston Park). 2009 Mar;23(3):239, 244, 252. No abstract available.

23.

The prognostic and predictive values of circulating HER-2/neu extracellular domain in patients with metastatic breast cancer.

Abu-Khalaf MM, Harris L.

Breast Cancer Res Treat. 2009 Apr;114(3):513-5. doi: 10.1007/s10549-008-0145-8. Epub 2008 Aug 2. No abstract available.

PMID:
18677560
24.

Breast sentinel lymph node dissection before preoperative chemotherapy.

Grube BJ, Christy CJ, Black D, Martel M, Harris L, Weidhaas J, Digiovanna MP, Chung G, Abu-Khalaf MM, Miller KD, Higgins SA, Philpotts L, Tavassoli FA, Lannin DR.

Arch Surg. 2008 Jul;143(7):692-9; discussion 699-700. doi: 10.1001/archsurg.143.7.692.

PMID:
18645113
25.

Long-term assessment of cardiac function after dose-dense and -intense sequential doxorubicin (A), paclitaxel (T), and cyclophosphamide (C) as adjuvant therapy for high risk breast cancer.

Abu-Khalaf MM, Juneja V, Chung GG, DiGiovanna MP, Sipples R, McGurk M, Zelterman D, Haffty B, Reiss M, Wackers FJ, Lee FA, Burtness BA.

Breast Cancer Res Treat. 2007 Sep;104(3):341-9. Epub 2006 Oct 19.

PMID:
17051423
26.

Five-year update of an expanded phase II study of dose-dense and -intense doxorubicin, paclitaxel and cyclophosphamide (ATC) in high-risk breast cancer.

Abu-Khalaf MM, Windsor S, Ebisu K, Salikooti S, Ananthanarayanan G, Chung GG, DiGiovanna MP, Haffty BG, Abrams M, Farber LR, Hsu AD, Reiss M, Zelterman D, Burtness BA.

Oncology. 2005;69(5):372-83. Epub 2005 Nov 24.

PMID:
16319508
27.

Volvulus of the sigmoid colon in Jordan.

Sroujieh AS, Farah GR, Jabaiti SK, el-Muhtaseb HH, Qudah MS, Abu-Khalaf MM.

Dis Colon Rectum. 1992 Jan;35(1):64-8.

PMID:
1733686
28.

Adrenal cysts: diagnosis and management.

Sroujieh AS, Farah GR, Haddad MJ, Abu-Khalaf MM.

Br J Urol. 1990 Jun;65(6):570-5.

PMID:
2372669
29.

Accessible standardized intracutaneous implants: pancreatic adenocarcinoma in the Syrian hamster.

LaMuraglia GM, Abu-Khalaf MM, Malt RA.

Br J Cancer. 1984 Aug;50(2):235-7. No abstract available.

Supplemental Content

Loading ...
Support Center